Structural basis for lipid-mediated activation of G protein-coupled receptor GPR55

Tobias Claff(Boehringer Ingelheim (Germany)), Dietmar Weichert(Boehringer Ingelheim (Germany)), Herbert Nar(Boehringer Ingelheim (Germany)), Jörg T. Kley(Boehringer Ingelheim (Germany)), Aniket Magarkar(Boehringer Ingelheim (Germany)), Rebecca Ebenhoch(Boehringer Ingelheim (Germany))
Nature Communications
February 25, 2025
10.1038/s41467-025-57204-y
Cited by 20

Related Papers

A specific antidote for dabigatran: functional and structural characterization
|Blood|2013|562
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
|Journal of Medicinal Chemistry|2007|285